Who owns PMV PHARMACEUTICALS INC?
- Ticker: PMVP
- CUSIP Number: 69353y103
Tip: Access positions for across all investors
Analyze quarterly positions in Pmv Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pmv Pharmaceuticals stock
Who bought or sold PMV PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 6.5M | $9.6M | 0% | Sep 2024 |
|
| Arrowpoint Asset Management | 3.6M | $5.4M | 30% | Sep 2024 |
|
| Sio Capital Management | 2.7M | $4.4M | 100% | Jun 2024 |
|
| Euclidean Capital | 2.6M | $3.9M | 0% | Sep 2024 |
|
| Vanguard Group | 2.3M | $3.7M | -7% | Jun 2024 |
|
| Acadian Asset Management | 2.1M | $3.1M | 0% | Sep 2024 |
|
| Partner Fund Management | 2.0M | $3.0M | 58% | Sep 2024 |
|
| BML Capital Management | 1.7M | $2.5M | 29% | Sep 2024 |
|
| BlackRock | 1.2M | $1.9M | -63% | Jun 2024 |
|
| BlackRock | 1.1M | $1.7M | 100% | Sep 2024 |
|
| Citadel Advisors | 1.1M | $1.6M | -38% | Sep 2024 |
|
| D. E. Shaw & Co | 1.0M | $1.6M | 2% | Sep 2024 |
|
| Goldman Sachs Group | 809k | $1.3M | -26% | Jun 2024 |
|
| Jacobs Levy Equity Management | 706k | $1.1M | -9% | Sep 2024 |
|
| Personal Cfo Solutions | 550k | $892k | 0% | Jun 2024 |
|
| Citigroup | 515k | $760k | 0% | Sep 2024 |
|
| Two Sigma Advisers | 494k | $800k | 35% | Jun 2024 |
|
| Connor, Clark & Lunn Investment Management | 441k | $657k | 0% | Sep 2024 |
|
| Acuitas Investments | 441k | $657k | 25% | Sep 2024 |
|
| Aldebaran Capital | 438k | $653k | 25% | Sep 2024 |
|
| Geode Capital Management | 433k | $645k | 1% | Sep 2024 |
|
| M^T Bank Corporation | 400k | $595k | 55% | Sep 2024 |
|
| Two Sigma Investments | 388k | $629k | -3% | Jun 2024 |
|
| Ghost Tree Capital | 375k | $608k | -44% | Jun 2024 |
|
| Assenagon Asset Management | 354k | $527k | 36% | Sep 2024 |
|
| Baker Bros. Advisors | 322k | $480k | 0% | Sep 2024 |
|
| Shay Capital | 165k | $268k | -16% | Jun 2024 |
|
| State Street Corporation | 145k | $235k | -82% | Jun 2024 |
|
| Bridgeway Capital Management | 140k | $227k | 87% | Jun 2024 |
|
| Evoke Wealth | 133k | $198k | 111% | Sep 2024 |
|
| Dimensional Fund Advisors | 126k | $188k | 0% | Sep 2024 |
|
| Bank of America Corporation | 121k | $180k | -65% | Sep 2024 |
|
| Morgan Stanley | 119k | $193k | -72% | Jun 2024 |
|
| Northern Trust | 87k | $130k | -74% | Sep 2024 |
|
| Jane Street | 74k | $110k | -55% | Sep 2024 |
|
| GSA Capital Partners | 73k | $109k | -6% | Sep 2024 |
|
| Qube Research & Technologies | 72k | $116k | 100% | Jun 2024 |
|
| Pnc Financial Services | 69k | $103k | 60% | Sep 2024 |
|
| Schonfeld Strategic Advisors | 67k | $100k | -48% | Sep 2024 |
|
| Marquette Asset Management | 64k | $95k | 0% | Sep 2024 |
|
| Marshall Wace | 62k | $92k | 378% | Sep 2024 |
|
| Squarepoint Ops | 51k | $83k | 100% | Jun 2024 |
|
| Susquehanna International | 44k | $66k | -49% | Sep 2024 |
|
| Hsbc Holdings | 44k | $72k | 0% | Jun 2024 |
|
| T. Rowe Price Associates | 34k | $51k | 0% | Sep 2024 |
|
| Point72 Asia | 32k | $48k | -49% | Sep 2024 |
|
| Barclays | 30k | $45k | -93% | Sep 2024 |
|
| Virtu Financial | 28k | $42k | 100% | Sep 2024 |
|
| Amundi | 26k | $39k | 0% | Sep 2024 |
|
| HighTower Advisors | 25k | $40k | 0% | Jun 2024 |
|
| State of Wyoming | 25k | $41k | -57% | Jun 2024 |
|
| Group One Trading | 16k | $24k | 24% | Sep 2024 |
|
| Tower Research Capital | 15k | $24k | 221% | Jun 2024 |
|
| Ohio Pers | 13k | $19k | -41% | Sep 2024 |
|
| Independent Advisor Alliance | 13k | $20k | 0% | Jun 2024 |
|
| Simplex Trading | 12k | $17k | -62% | Sep 2024 |
|
| CI Private Wealth | 10k | $15k | 0% | Sep 2024 |
|
| Cubist Systematic Strategies | 8.6k | $13k | -88% | Sep 2024 |
|
| Federated Investors | 8.2k | $12k | 112% | Sep 2024 |
|
| Russell Investments | 4.7k | $7.6k | 100% | Jun 2024 |
|
| Macquarie Group | 2.1k | $3.4k | 100% | Jun 2024 |
|
| Nordwand Advisors | 2.0k | $3.0k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 1.3k | $2.0k | 100% | Sep 2024 |
|
| Jpmorgan Chase & Co | 1.0k | $1.5k | -99% | Sep 2024 |
|
| NISA Investment Advisors | 105.00 | $155.998500 | 62% | Sep 2024 |
|
| Royal Bank of Canada | 48.00 | $0 | -98% | Sep 2024 |
|
Who sold out of Pmv Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 759k | $1.2M |
| EcoR1 Capital | Mar 2024 | 567k | $964k |
| Opaleye Management | Jun 2024 | 475k | $770k |
| Exome Asset Management | Jun 2024 | 358k | $581k |
| Verition Fund Management | Mar 2024 | 201k | $342k |
| Charles Schwab Investment Management | Jun 2024 | 179k | $289k |
| Nuveen Asset Management | Mar 2024 | 153k | $260k |
| XTX Topco | Jun 2024 | 148k | $239k |
| AQR Capital Management | Jun 2024 | 119k | $192k |
| Centiva Capital | Jun 2024 | 77k | $125k |
| Fishman Jay A | Jun 2024 | 70k | $113k |
| Man Group | Jun 2024 | 62k | $101k |
| Alliancebernstein | Mar 2024 | 51k | $86k |
| American Century Companies | Jun 2024 | 50k | $81k |
| Sunrise Partners Limited Partnership | Jun 2024 | 35k | $57k |
| Y-Intercept | Jun 2024 | 32k | $51k |
| Rhumbline Advisers | Jun 2024 | 23k | $37k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 21k | $34k |
| PanAgora Asset Management | Mar 2024 | 19k | $32k |
| Algert Coldiron Investors | Jun 2024 | 15k | $25k |
| Point72 | Jun 2024 | 15k | $24k |
| Hrt Financial | Jun 2024 | 12k | $19k |
| Jump Financial | Jun 2024 | 12k | $19k |
| Quantbot Technologies | Mar 2024 | 5.3k | $9.1k |
| Private Wealth Management Group | Mar 2024 | 676.00 | $1.2k |
| New York State Common Retirement Fund | Jun 2024 | 341.00 | $1.0k |
| Capital Advisors | Jun 2024 | 322.00 | $1.0k |
| CWM | Jun 2024 | 230.00 | $0 |